Top 20 of Diabetic Angiopathies

Article title # Publications/# Citations

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

1998:

1580

Biochemistry and molecular cell biology of diabetic complications.

2001: MBrownlee;

846

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

2008: ADVANCE Collaborative group; LBillot; SBompoint; JChalmers; MCooper; BEde Galan; PGlasziou; DGrobbee; ... PHamet; SHarrap; SHeller; RJoshi; LLiu; SMacMahon; GMancia; MMarre; CEMogensen; BNeal; CPan; APatel; NPoulter; ARodgers; FTravert; BWilliams; MWoodward;

617

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.

2000: AIAdler; CACull; DHadden; RRHolman; SEManley; DRMatthews; HANeil; IMStratton; RCTurner;

578

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

1998:

547

10-year follow-up of intensive glucose control in type 2 diabetes.

2008: MABethel; RRHolman; DRMatthews; HANeil; SKPaul;

545

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

1998:

523

Glucose control and vascular complications in veterans with type 2 diabetes.

2008: VADT Investigators; CAbraira; SNDavis; WDuckworth; NEmanuele; SGoldman; RHayward; WGHenderson; ... GDHuang; JMarks; MMcCarren; TMoritz; PDReaven; DReda; MEVitek; SRWarren; FJZieve;

410

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

2003: SCORE project group; RMConroy; GDe Backer; DDe Bacquer; PDucimetiere; APFitzgerald; IMGraham; PJousilahti; ... UKeil; AMenotti; INjølstad; RGOganov; KPyörälä; SSans; TThomsen; HTunstall-Pedoe; ATverdal; HWedel; PWhincup; LWilhelmsen;

315

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

1993: JDNeaton; JStamler; OVaccaro; DWentworth;

307

Diabetes and cardiovascular disease. The Framingham study.

1979: WBKannel; DLMcGee;

287

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

2000: YArita; TFunahashi; THanafusa; KHasegawa; KHotta; HIwahashi; SKihara; HKuriyama; ... KMaeda; MMatsuda; YMatsuzawa; MMuraguchi; TNakajima; TNakamura; MNishida; YOhmoto; YOkamoto; NOuchi; NSakai; MTakahashi; SYamashita;

278

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

2000:

230

Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth.

1993: DJBarker; PMClark; CHFall; CNHales; COsmond; KPhipps;

213

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes.

2004: CCCowie; JFradkin; SHSaydah;

208

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.

2002: JABeckman; MACreager; PLibby;

197

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

1995: EAraki; NFuruyoshi; SIsami; HKishikawa; YKojima; TMiyata; SMotoyoshi; YOhkubo; MShichiri;

189

Ethnic disparities in diabetic complications in an insured population.

2002: LMAckerson; AFerrara; AJKarter; JYLiu; HHMoffet; JVSelby;

177

Association of depression and diabetes complications: a meta-analysis.

2001 Jul-Aug: RAnderson; REClouse; Mde Groot; KEFreedland; PJLustman;

174

Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

2007: European Association for the Study of Diabetes (EASD); Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); MBartnik; MBertrand; JBetteridge; JJBlanc; ABudaj; JCamm; ... BCharbonnel; FCosentino; MJde Boer; VDean; JDeckers; JWDeckers; KDickstein; EErdmann; EFerrannini; AFlyvbjerg; HGohlke; IGraham; BJonsson; JRJuanatey; MLaakso; JLekakis; PLindgren; KMalmberg; KMcGregor; MMetra; PFMonteiro; JMorais; JÖstergren; AOsterspey; KParhofer; SPriori; SGPriori; KPyörälä; QQiao; IRaz; LRydén; GSchernthaner; EStandl; MStramba-Badiale; JTamargo; IThrainsdottir; JTuomilehto; GVan den Berghe; IVanhorebeek; MVolpe; DWood; JLZamorano;

164